Devonian Health Group Inc. carries a market capitalization of 19.47M, placing it among publicly traded companies globally. Its enterprise value stands at 39.46M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 19.47M |
| Enterprise Value | 39.46M |
Devonian Health Group Inc. currently has 2.78M shares outstanding.
| Shares Outstanding | 2.78M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 13.37, and the price-to-book ratio stands at -5.43.
| PE Ratio | N/A |
| PS Ratio | 13.37 |
| PB Ratio | -5.43 |
| P/TBV Ratio | 19.28 |
| P/FCF Ratio | -3.40 |
| P/OCF Ratio | -3.40 |
| EV / Sales | 13.17 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Devonian Health Group Inc. maintains a current ratio of 1.00, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.01, indicating elevated leverage, while an interest coverage ratio of -690.83 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.00 |
| Quick Ratio | 0.78 |
| Debt / Equity | 2.01 |
| Debt / EBITDA | -0.02 |
| Interest Coverage | -690.83 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -38.71 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 35.76 |
| Income Tax | -12,684.00 |
| Effective Tax Rate | N/A |
Devonian Health Group Inc.'s stock has declined approximately -35.18519% over the past 52 weeks. The 50-day moving average sits at 9.19, while the 200-day moving average is 7.25.
| Beta (5Y) | N/A |
| 52-Week Price Change | -35.18519% |
| 50-Day Moving Average | 9.19 |
| 200-Day Moving Average | 7.25 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Devonian Health Group Inc. generated 3.00M in revenue and converted that into -6.11M in net income, yielding earnings per share of -2.21. EBITDA reached -5.98M, while operating income came in at -6.19M.
| Revenue | 3.00M |
| Gross Profit | 2.03M |
| Operating Income | -6.19M |
| Pretax Income | -6.13M |
| Net Income | -6.11M |
| EBITDA | -5.98M |
| EBIT | -6.19M |
| Earnings Per Share (EPS) | -2.21 |
Devonian Health Group Inc. holds 719,932.00 in cash and equivalents against 140,543.00 in total debt, resulting in a net debt position of -719,932.00. Total book value stands at -7.38M, with working capital of -5,177.00 providing operational flexibility.
| Cash & Cash Equivalents | 719,932.00 |
| Total Debt | 140,543.00 |
| Net Debt | -719,932.00 |
| Equity (Book Value) | -7.38M |
| Book Value Per Share | -2.67 |
| Working Capital | -5,177.00 |
Devonian Health Group Inc. produced -11.77M in operating cash flow over the past twelve months. After subtracting -6,500.00 in capital expenditures, free cash flow totaled -11.77M - equivalent to -4.26 per share.
| Operating Cash Flow | -11.77M |
| Capital Expenditures | -6,500.00 |
| Free Cash Flow | -11.77M |
| FCF Per Share | -4.26 |
Devonian Health Group Inc. operates with a gross margin of 67.89, reflecting its pricing power and cost economics. The operating margin of -206.69 and net profit margin of -204.08 provide insight into operational efficiency.
| Gross Margin | 67.89 |
| Operating Margin | -206.69 |
| Pretax Margin | -204.51 |
| Profit Margin | -204.08 |
| EBITDA Margin | -199.80 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -6.82 |
| FCF Yield | -29.37 |
Devonian Health Group Inc.'s most recent stock split took place on January 22, 2026 with a 60:1 split ratio.
| Last Split Date | 1/22/2026 |
| Split Ratio | 60:1 |
Devonian Health Group Inc. posts an Altman Z-Score of -4.78, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -4.78 |